NCT01861782

Brief Summary

Prospective open label crossover self controlled study. The study population will randomly be divided into two groups. The study will take place in Lot Spa Hotel at the Dead Sea in two cycles (one of 16 participants and one of 14 participants) and will be comprised of 3 main stages:

  1. 1.Initial exposure to treatment for 14 days excluding Friday and Saturday (each of the two groups will have its own treatment protocol)
  2. 2.12-month washout period
  3. 3.Crossover of the two groups and second exposure to treatment for 14 days excluding Friday and Saturday (each of the two groups will have its own treatment protocol).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2013

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 24, 2013

Completed
8 days until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Last Updated

March 26, 2014

Status Verified

March 1, 2014

Enrollment Period

2 years

First QC Date

May 12, 2013

Last Update Submit

March 25, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessing the change in DAS28 (Disease Activity Score) between the baseline and several occasions after each one of the proposed treatments.

    DAS28 will be evaluated before and immediately after the treatment, as well as one and 3 months after treatment has started

    up to 4 months

Secondary Outcomes (1)

  • Assessing the change between baseline and several occasions after each one of proposed the treatments

    up to 4 months

Study Arms (2)

Dead Sea Solar and Water Treatment

EXPERIMENTAL

Dead Sea Solar and Water Treatment

Other: Dead Sea Solar and Water Treatment

Sulfur Pool & Medicinal Mud

EXPERIMENTAL

Sulfur Pool \& Medicinal Mud

Other: Sulfur Pool & Medicinal Mud

Interventions

Dead Sea Solar and Water Treatment
Sulfur Pool & Medicinal Mud

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female ≥ 18
  • Patients with diagnosed rheumatoid arthritis
  • Patients with moderate disease activity (DAS28 \> 3.2)

You may not qualify if:

  • Patients who suffer from Photosensitivity
  • Patients with Suspected Lupus Erythematoides
  • Patients with tendency to sudden loss of consciousness and/or dizziness
  • Patients under chemotherapeutic treatment
  • Patients with Active Malignancy
  • Patients with lowest level of physical functioning (class 4)
  • Patients with serious uncontrolled concomitant chronic disease
  • Drug Abuser
  • Patients with severe peripheral venous insufficiency
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lot Spa Hotel at the Dead Sea

Ein Bokek, Israel

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Water Purification

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Waste ManagementSanitary EngineeringSanitationCommunicable Disease ControlPublic Health PracticePublic HealthEnvironment and Public Health

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Rheumatology Clinic

Study Record Dates

First Submitted

May 12, 2013

First Posted

May 24, 2013

Study Start

June 1, 2013

Primary Completion

June 1, 2015

Last Updated

March 26, 2014

Record last verified: 2014-03

Locations